Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niaspan for the treatment of endothelial dysfunction in patients without hyperlipoproteinemia
2007-002023-32Phase 2Terminated
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of niacin in endothelial dysfunction, sponsored by Charité – Universitätsmedizin Berlin. Primary endpoints: Improvement of endothelial function and Mobilization of endothelial progenitor cells. Started Jun 2007; status: terminated.
02
Drugs
niacin
03
Conditions
endothelial dysfunction
Beyond the preview
Go deeper on 2007-002023-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002023-32.